Synvisc (hylan G-F 20) Patient Assistance Program
Don’t let the high cost of brand intra-articular hyaluronic acid disrupt your knee osteoarthritis treatment. We help eligible patients access Synvisc (hylan G-F 20 intra-articular knee injection) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Synvisc (hylan G-F 20) is FDA-approved for treatment of pain in patients with osteoarthritis (OA) of the knee who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Intra-articular knee injection series (3 weekly injections). Cross-linked hyaluronic acid — viscosupplementation.
- Without assistance, Synvisc costs commonly run approximately $600–$1,200 per injection (~$1,800–$3,600 for full series).
- Through AffordMyPrescriptions, qualifying patients can access Synvisc for a flat $69.95 per month.
- Other viscosupplementation products for knee OA: Synvisc-One (single injection dosing — brand), Hyalgan, Supartz, Euflexxa, Orthovisc, Gel-One, Monovisc, Genvisc — many brand and biosimilar/generic hyaluronic acid products. Standard knee OA management: weight loss, physical therapy, exercise, acetaminophen, NSAIDs (topical or oral generic), duloxetine (generic), intra-articular corticosteroid injections (generic — significantly cheaper than viscosupplementation), platelet-rich plasma (variable evidence), surgical (total knee replacement for advanced disease). Effectiveness of viscosupplementation modest and debated in evidence-based guidelines.
What is Synvisc Prescription Assistance Program?
The Synvisc Patient Assistance Program helps eligible patients access this intra-articular knee viscosupplementation at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Synvisc PAP enrollment for a flat $69.95 per month — so you never face a gap in Synvisc knee OA therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Synvisc enrollment — so you never face a gap in your knee osteoarthritis treatment.
Pharmacy Price Comparison
- Without assistance, Synvisc costs hundreds per injection. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Corticosteroid injection (alt) | ~$50/injection | Cheap generic alt IA |
| Orthopedic clinic | ~$800/injection | Save substantially |
| Rheumatology clinic | ~$1,000/injection | Save substantially |
| Hospital outpatient | ~$1,200/injection | Save substantially |
| 340B-eligible institution | ~$600/injection | Save substantially |
| Synvisc-One (single inj alt) | ~$1,800/dose | Alt single-injection HA |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Synvisc — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Synvisc Prescription Program?
The Synvisc Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Standard knee OA management prioritizes weight loss, physical therapy, and simple analgesics. Corticosteroid injections (generic) are cheaper intra-articular alternative. Viscosupplementation evidence is modest per updated OA guidelines.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Synvisc assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Synvisc is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Synvisc:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $600–$1,200/injection per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Synvisc assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Synvisc Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Synvisc:
Synvisc is a cross-linked hyaluronic acid intra-articular knee injection for symptomatic knee osteoarthritis inadequately controlled with conservative measures. Viscosupplementation approach. 3-injection weekly series. Alternative single-injection formulation: Synvisc-One.
How It Works:
Knee osteoarthritis (OA) is a common cause of pain and disability. Cartilage degeneration and synovial changes contribute to joint pain, stiffness, and functional limitation. Synovial fluid in OA has reduced hyaluronic acid concentration and viscosity vs healthy joints. Viscosupplementation aims to restore synovial fluid viscoelasticity. Hylan G-F 20 (Synvisc) is a cross-linked hyaluronic acid product — higher molecular weight and viscosity than native hyaluronic acid. Intra-articular knee injection restores viscosupplementation temporarily. Mechanism may include mechanical lubrication, anti-inflammatory effects, and cartilage protection. Effectiveness of viscosupplementation for knee OA is modest and debated — updated OA management guidelines (ACR, OARSI) provide conditional or limited recommendations. Some patients experience significant symptomatic benefit, others don’t.
Form and Use:
Synvisc intra-articular knee injection. 3-injection weekly series (weeks 0, 1, 2). Ultrasound guidance or anatomic technique. Given at orthopedic, rheumatology, or specialty knee clinic. Series can be repeated at intervals if symptomatic benefit was achieved.
Generic Availability:
No generic Synvisc. Other viscosupplementation products for knee OA: Synvisc-One (single 6 mL injection dosing — brand; convenience alternative), Hyalgan, Supartz, Euflexxa, Orthovisc, Gel-One, Monovisc, Genvisc — many brand and biosimilar/generic hyaluronic acid products with varying cost. Standard knee OA management: weight loss (evidence-based first-line intervention), physical therapy, low-impact exercise (walking, cycling, swimming, aquatic therapy), acetaminophen (very cheap generic), NSAIDs — topical (diclofenac gel over-the-counter or generic Rx) or oral generic (naproxen, ibuprofen, meloxicam, celecoxib generic), duloxetine (generic), intra-articular corticosteroid injections (generic — very cheap; effective for OA flares but not for repeated chronic use given cartilage concerns), platelet-rich plasma (variable evidence), stem cell injections (unproven), total knee replacement for advanced disease. Arthritis Foundation resources.
Warnings:
Injection site pain, swelling, and effusion (post-injection reaction — can be significant), avian protein sensitivity contraindication (Synvisc contains avian-derived hyaluronic acid; not for use in patients with hypersensitivity to avian proteins), infection risk with intra-articular procedure (rare — septic arthritis), pseudogout crystalline flare (rare — with any intra-articular procedure), embryo-fetal considerations (systemic exposure minimal but caution in pregnancy), hypersensitivity reactions. Other: injection site reactions, arthralgia. Series repeat only if prior series provided symptomatic benefit.
FAQ (Frequently Asked Questions)
How much does Synvisc cost without insurance?
$600–$1,200 per injection at orthopedic clinics. Full 3-injection series $1,800–$3,600. Synvisc-One (single injection alternative) similar total course cost. Intra-articular corticosteroid injections cost ~$50 (generic) — significantly cheaper alternative for OA flares.
How is Synvisc different from Synvisc-One?
Same active ingredient (hylan G-F 20). Synvisc is 3-injection weekly series. Synvisc-One is single 6 mL injection — convenience advantage but similar effectiveness per FDA. Both are brand hyaluronic acid viscosupplementation. Discuss with prescriber which is preferred.
How does Synvisc compare to intra-articular corticosteroid injection?
Corticosteroid injections (generic — very cheap) provide effective short-term symptomatic relief for OA flares — often preferred first for symptomatic knee OA. Repeated corticosteroid use is limited by cartilage concerns. Viscosupplementation may provide longer duration of benefit (months) for select patients. Evidence for viscosupplementation is modest per updated OA guidelines.
What is the evidence for viscosupplementation?
Evidence for hyaluronic acid viscosupplementation in knee OA is modest and debated. Updated OA management guidelines (ACR, OARSI, AAOS) provide conditional or limited recommendations. Some patients experience significant symptomatic benefit; others don’t. Weight loss, physical therapy, and simple analgesics remain first-line.
How long does Synvisc effect last?
Symptomatic benefit typically lasts several months (variable — some patients experience >6 months benefit, others less). Series can be repeated at ~6-month intervals if prior series provided benefit.
Take Control of Your Medication Costs
Effective knee osteoarthritis management preserves function and quality of life. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.